Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

04 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/04/3306659/0/en/onco360-has-been-selected-as-a-national-specialty-pharmacy-provider-for-jylamvo-methotrexate-oral-solution.html

02 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/02/3305615/0/en/onco360-has-been-selected-as-a-national-specialty-pharmacy-provider-for-imkeldi-imatinib-oral-solution.html

28 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260127385856/en/Shorla-Oncology-Announces-U.S.-FDA-Approval-of-Larger-Vial-Size-for-Nelarabine-Intravenous-Administration-for-the-Treatment-of-T-cell-Acute-Lymphoblastic-Leukemia-and-T-cell-Lymphoblastic-Lymphoma

15 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250715632403/en/Shorla-Oncology-Announces-FDA-Orphan-Drug-Designation-for-SH-110-to-Treat-Rare-Brain-Cancer-Using-Oral-Liquid

29 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250429747360/en/Shorla-Oncology-Announces-FDA-Approval-of-TEPYLUTE-100mg-First-and-Only-Ready-to-Dilute-Multi-Dose-Vial-of-Thiotepa-to-Treat-Breast-and-Ovarian-Cancer-and-Commercial-Launch-of-TEPYLUTE-15mg-and-100mg-Vials-in-the-U.S.

04 Mar 2025
// BUSINESSWIRE
ABOUT THIS PAGE